Survival Outcomes After Immune-Related Adverse Events in Older Adults With Advanced Non-Small Cell Lung Cancer.
BACKGROUND Immune-related adverse events (irAEs) are common toxicities of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC), but their prognostic implications in older adults remain uncertain. PATIENTS AND METHODS We conducted a retrospective cohort study using SEER-Medicare (2010-2019). We in...